glp-1/gip Biology of Incretins: GLP-1 and GIP Biology of Incretins: GLP-1 and

This analysis was part of the IMI-Stratification of Obesity Phenotypes to Optimize Future Obesity Therapy (IMI-SOPHIA) project

Gastrointestinal issues such as nausea, vomiting, diarrhea, and abdominal pain are among the most frequently reported side effects, especially at the start of treatment

Andrew Stokes received a grant from the Robert Wood Johnson Foundation analyze the real-word effects of this new class of appetite-suppressing therapies, as well as inequities in access to these medications.

Jardiance Jardiance (Empagliflozin) Diabetes & Heart Failure SGLT2 Inhibitor Jardiance No Empagliflozin Prescription-only Targeted Conditions Jardiance is approved to treat the following conditions: Type 2 Diabetes Mellitus (T2DM), to improve glycemic control Heart Failure with Reduced Ejection Fraction (HFrEF), to reduce the risk of cardiovascular death and

GLP-1 RAs are used for managing blood glucose levels in people with type 2 diabetes mellitus and have also been licensed for use in weight loss treatment

Natural GLP1 plays a crucial role in regulating appetite, blood sugar, and overall metabolic health, yet many seek ways to enhance its levels without relying on medication